Clinical trials
Shock, Septic trials in the United States with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
39 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 1 |
| 2007 | 1 |
| 2008 | 1 |
| 2010 | 2 |
| 2011 | 2 |
| 2013 | 1 |
| 2014 | 3 |
| 2015 | 1 |
| 2016 | 1 |
| 2017 | 2 |
| 2018 | 2 |
| 2019 | 4 |
| 2020 | 2 |
| 2021 | 4 |
| 2022 | 3 |
| 2023 | 2 |
| 2024 | 1 |
| 2026 | 5 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 19 |
| Recruiting | 6 |
| Terminated | 5 |
| Unknown status | 5 |
| Not yet recruiting | 2 |
| Active, not recruiting | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Dascena | 2 |
| Intermountain Health Care, Inc. | 2 |
| National Institute of General Medical Sciences (NIGMS) | 2 |
| Rhode Island Hospital | 2 |
| Spectral Diagnostics (US) Inc. | 2 |
| Vanderbilt University | 2 |
| American Burn Association | 1 |
| Beth Israel Deaconess Medical Center | 1 |
| BioMérieux | 1 |
| Children's Hospital of Philadelphia | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Shock, Septic | 39 |
| Sepsis | 32 |
| Critical Illness | 4 |
| Acute Kidney Injury | 3 |
| Respiratory Distress Syndrome | 3 |
| Communicable Diseases | 2 |
| Emergencies | 2 |
| Endotoxemia | 2 |
| Shock | 2 |
| Apnea | 1 |
Trials
Showing 1 to 25 of 39. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.